Metastasis After Radical Prostatectomy or External Beam Radiotherapy for Patients With Clinically Localized Prostate Cancer: A Comparison of Clinical Cohorts Adjusted for Case Mix

作者: Michael J. Zelefsky , James A. Eastham , Angel M. Cronin , Zvi Fuks , Zhigang Zhang

DOI: 10.1200/JCO.2009.22.2265

关键词:

摘要: Purpose We assessed the effect of radical prostatectomy (RP) and external beam radiotherapy (EBRT) on distant metastases (DM) rates in patients with localized prostate cancer treated RP or EBRT at a single specialized center. Patients Methods clinical stages T1c-T3b were intensity-modulated ( 81 Gy) RP. Both cohorts included salvage androgendeprivation therapy for biochemical failure. Salvage was delivered median 13 months after failure compared 69 patients. DM controlling patient age, stage, serum prostate-specific antigen level, biopsy Gleason score, year treatment. Results The 8-year probability freedom from metastatic progression 97% 93% After adjustment case mix, surgery associated reduced risk metastasis (hazard ratio, 0.35; 95% CI, 0.19 to 0.65; P .001). similar cancer–specific mortality 0.32; 0.13 0.80; .015). Rates favorable-risk disease (1.9% difference metastasis-free survival), somewhat intermediate-risk (3.3%), more substantially unfavorable-risk (7.8% progression). Conclusion Metastatic is infrequent men low-risk either EBRT. higher-risk had lower death than These results may be confounded by differences use timing therapy. J Clin Oncol 28:1508-1513. © 2010 American Society Clinical Oncology

参考文章(36)
Jay P. Ciezki, Eric A. Klein, Kenneth Angermeier, James Ulchaker, Nabil Chehade, Andrew Altman, Arul Mahadevan, Chandana A. Reddy, A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy International Journal of Radiation Oncology Biology Physics. ,vol. 60, pp. 1347- 1350 ,(2004) , 10.1016/J.IJROBP.2004.05.067
Oren Cahlon, Michael J. Zelefsky, Alison Shippy, Heather Chan, Zvi Fuks, Yoshiya Yamada, Margie Hunt, Steven Greenstein, Howard Amols, Ultra-High Dose (86.4 Gy) IMRT for Localized Prostate Cancer: Toxicity and Biochemical Outcomes International Journal of Radiation Oncology Biology Physics. ,vol. 71, pp. 330- 337 ,(2008) , 10.1016/J.IJROBP.2007.10.004
Anthony L. Zietman, Michelle L. DeSilvio, Jerry D. Slater, Carl J. Rossi, Daniel W. Miller, Judith A. Adams, William U. Shipley, Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate JAMA. ,vol. 294, pp. 1233- 1239 ,(2005) , 10.1001/JAMA.294.10.1233
Michael J. Zelefsky, Victor E. Reuter, Zvi Fuks, Peter Scardino, Alison Shippy, Influence of Local Tumor Control on Distant Metastases and Cancer Related Mortality After External Beam Radiotherapy for Prostate Cancer Journal of Urology. ,vol. 179, pp. 1368- 1373 ,(2008) , 10.1016/J.JURO.2007.11.063
Stephen J. Freedland, Alan W. Partin, Elizabeth B. Humphreys, Leslie A. Mangold, Patrick C. Walsh, Radical prostatectomy for clinical stage T3a disease. Cancer. ,vol. 109, pp. 1273- 1278 ,(2007) , 10.1002/CNCR.22544
Peter B. Morgan, Alexandra L. Hanlon, Eric M. Horwitz, Mark K. Buyyounouski, Robert G. Uzzo, Alan Pollack, Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy. Cancer. ,vol. 110, pp. 68- 80 ,(2007) , 10.1002/CNCR.22755
A. J. Vickers, F. J. Bianco, A. M. Serio, J. A. Eastham, D. Schrag, E. A. Klein, A. M. Reuther, M. W. Kattan, J. E. Pontes, P. T. Scardino, The Surgical Learning Curve for Prostate Cancer Control After Radical Prostatectomy Journal of the National Cancer Institute. ,vol. 99, pp. 1171- 1177 ,(2007) , 10.1093/JNCI/DJM060
M. Roach, M. DeSilvio, C. Lawton, V. Uhl, M. Machtay, M.J. Seider, M. Rotman, C. Jones, S.O. Asbell, R.K. Valicenti, S. Han, C.R. Thomas, W.S. Shipley, Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. Journal of Clinical Oncology. ,vol. 21, pp. 1904- 1911 ,(2003) , 10.1200/JCO.2003.05.004
A Pollack, G.K Zagars, G Starkschall, J.A Antolak, J.J Lee, E Huang, A.C von Eschenbach, D.A Kuban, I Rosen, Mark A Ritter, Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial Urologic Oncology-seminars and Original Investigations. ,vol. 21, pp. 306- ,(2003) , 10.1016/S1078-1439(03)00092-9